Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Dual specificity protein kinase CLK1 | ||
Ligand | BDBM50505743 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1823776 (CHEMBL4323540) | ||
IC50 | 3100±n/a nM | ||
Citation | Degorce, SL; Anjum, R; Bloecher, A; Carbajo, RJ; Dillman, KS; Drew, L; Halsall, CT; Lenz, EM; Lindsay, NA; Mayo, MF; Pink, JH; Robb, GR; Rosen, A; Scott, JS; Xue, Y Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88 J Med Chem62:9918-9930 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Dual specificity protein kinase CLK1 | |||
Name: | Dual specificity protein kinase CLK1 | ||
Synonyms: | CDC-like kinase 1 | CDC-like kinase 1 (CLK1) | CDC2-like kinase 1 (CLK1) | CLK | CLK1 | CLK1_HUMAN | Dual specificity protein kinase CLK1 | Dual specificity protein kinase CLK1/CLK4 | Dual specificty protein kinase CLK1 | ||
Type: | Protein | ||
Mol. Mass.: | 57322.21 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P49759 | ||
Residue: | 484 | ||
Sequence: |
| ||
BDBM50505743 | |||
n/a | |||
Name | BDBM50505743 | ||
Synonyms: | CHEMBL4582624 | ||
Type | Small organic molecule | ||
Emp. Form. | C25H32N10O2 | ||
Mol. Mass. | 504.5874 | ||
SMILES | COC(=O)N1CCN(CC1)[C@H]1CC[C@@H](CC1)Nc1nc(Nc2cnn(C)c2)nc2ccc(CC#N)nc12 |r,wU:13.17,wD:10.10,(21.97,-21.58,;21.98,-20.04,;20.66,-19.26,;20.68,-17.72,;19.32,-20.02,;19.31,-21.56,;17.97,-22.32,;16.64,-21.54,;16.65,-19.99,;17.99,-19.23,;15.3,-22.29,;13.96,-21.52,;12.62,-22.28,;12.62,-23.82,;13.95,-24.6,;15.29,-23.83,;11.28,-24.59,;11.28,-26.13,;12.62,-26.91,;12.62,-28.45,;13.95,-29.22,;15.28,-28.46,;15.43,-26.92,;16.94,-26.61,;17.7,-27.94,;19.24,-27.93,;16.67,-29.08,;11.28,-29.22,;9.95,-28.45,;8.63,-29.24,;7.29,-28.48,;7.27,-26.93,;5.93,-26.19,;5.91,-24.65,;5.88,-23.11,;8.6,-26.15,;9.94,-26.91,)| | ||
Structure |